Design, development, and evaluation of controlled-release and targeted drug delivery systems; bioavailability classification, evaluation, and in-vitro and in-vivo correlation of (as per FDA guidelines) of oral, topical and novel drug delivery systems, clinical and metabolic investigation of anticancer agents.